🇺🇸 FDA
Patent

US 7772230

Chroman compound, processes for its preparation, and its pharmaceutical use

granted A61PA61P9/06

Quick answer

US patent 7772230 (Chroman compound, processes for its preparation, and its pharmaceutical use) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CHINA PHARMACEUTICAL UNIVERSITY
Grant date
Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P9/06